Alvarez & Marsal

On December 15, 2024, Bahrain’s National Bureau for Revenue (NBR) issued the Executive Regulations for the Domestic Minimum Top-Up Tax (DMTT). This follows the September release of Decree-Law No. 11 of 2024, introducing a 15% Global Minimum Tax (GMT) for large Multinational Enterprises (MNEs). These new regulations provide crucial clarifications on the DMTT framework. Discover the key highlights in our latest tax alert: https://okt.to/Y2gViT #AMon #DMTT #Pillar2 #MiddleEast #TaxAlert

The Alvarez & Marsal Unsecured Creditors’ Committee Team is proud to represent the Official Committee of Unsecured Creditors of Northvolt. https://okt.to/jndzRV #AMon #UCC #UnsecuredCreditorsCommittee #Restructuring #Bankruptcy

Foreign Investment Watch recently featured an article by A&M's National Security, Trade and Technology experts Randall Cook and Vincent Mekles. In the article "Getting Ready for the Bulk Sensitive Data Rule; Practical Considerations," Randall and Vince explore the implications of the DOJ's proposed Bulk Sensitive Data Rule and provide key considerations for companies preparing for the final regulation. Read the article here: https://okt.to/HofL16 #AMon #SensitiveData #NationalSecurity

In conflict management, the first meeting of parties can make or break the resolution process. How can organizations, investors or shareholders navigate these crucial conversations effectively? In this edition of Raising the Bar, Managing Director Mikhail Krapivin shares key strategies for approaching initial meetings in contentious matters. From managing heightened emotions to driving productive discussions, Mikhail outlines how to lay the groundwork for resolution in even the most challenging disputes. Explore how preparation and clarity can turn challenging discussions into opportunities for progress. Read the full article here: https://okt.to/3LqbKp #AMon #Disputes #ConflictResolution

As we reflect on the past year, our Q4 2024 Infrastructure Pulse Survey Report, developed in partnership with the Global Infrastructure Investor Association (GIIA), explores the primary factors shaping global investor confidence in the infrastructure sector within Australia, Europe and North America. This report provides insights into essential elements that impact investment decisions in infrastructure by analyzing trends, challenges, and new opportunities. Our goal is to equip investors and stakeholders with the tools they need to navigate this dynamic market effectively by providing a biannual temperature check. Read the full report here: https://okt.to/8FNyl2 #AMon #InfrastructureInvestment Jay Moody, Wayne Jephson, Jason Clatworthy, Michael R Farkas, Paul Aversano, Anthony Caporrino, Xuong Liu, Fabio G. Pires, Jonathan Gibbons, Bhavik Hathi, Ashish Bansal, Philip Mitchell, Stella Yuan, Scott Foster, David Willis, Vivian Santora, Victoria Whitman, Jack Hollyman, Craig Forrest, Kanat Emiroglu, Jimmy Glenn, Markus Lahrkamp, Andy W., Julie McLaughlin

Is your biopharma strategy ready for 2025? With portfolio risks, pipeline challenges, policy shifts, and economic uncertainty on the horizon, navigating the future necessitates strategic decision-making backed by data-driven insights. A&M’s Corporate Transaction Group is excited to share The 2024 Biopharmaceutical M&A and Venture Capital Insights, part of our ‘Welcome to the Future Series.’ This report explores M&A and VC trends in 2024, offering perspectives and actionable insights to help prepare for an evolving life sciences industry heading into 2025. This report provides a comprehensive overview of dealmaking within the Biopharmaceutical industry including: M&A Trends: How have biopharma dealmakers approached M&A on the quest for innovation? Venture Capital Insights: How are VCs actively remaining ahead of the curve in pursuit of novel technologies? Policy Impacts: How could public policy play a continued role in shaping global M&A and VC activity? 2025 Outlook: Which possible market forces could influence M&A and VC activity starting in the new year? Unlock the knowledge you need to lead this transformation. Access the full report now and click the link below: https://okt.to/KpoIaW #AMon #BiotechTrends #Innovation #VentureCapital #MandA #LifeSciences #Biopharma #FutureofBiotech We would like to thank the authors and contributors for their diligent work on this report. J. Preston Parker, Mark Freitas, Marcos Cortes, M.Sc., Simon Joyeux, Anand Seshadri, Sean Helmig, Lyna Sun, James Guyton, David Müller-Elmau, Daaron Dohler, MBA, Marilyn Adan, Marwan Ramadan, Amit Malik, Kishan Patel Paul Aversano, Jeff Wilson, Colin Harvey, Kevin M., Mat Hency, Nancy T., Anthony Caporrino, Katia Lacy, Stacy Kirshner, Greg Cibuzar, Alison Fink, Jeremy Nanus, Vivian Santora, Joe Deegan, Ginger Kelley, Jeff Wilson, David Evans, Manish Gupta

A&M’s Corporate Transactions Group (CTG) is happy to announce the addition of Lyna Sun as Managing Director in Miami, marking another milestone in the practice’s ongoing growth. With over 20 years of experience in executing complex corporate transactions—including buy- and sell-side deals, spin-offs, IPOs, joint ventures, and large-scale transformations—Lyna's expertise further strengthens CTG’s capabilities as a globally integrated advisor. Lyna specializes in operational due diligence, synergy identification and realization, divestiture cost analysis and transition planning, and cross-functional execution both pre- and post-close. Her extensive work in life sciences, healthcare, energy, financial services, and consumer and retail across 125+ countries will significantly enhance our ability to support clients in navigating transformative deals and creating lasting value. Learn more: https://okt.to/FXe8av #AlvarezandMarsal #CorporateTransactionsGroup #AMon J. Preston Parker, Joe Deegan, Paul Aversano, Jeff Wilson, Colin Harvey, Kevin M.

A&M’s Corporate Transactions Group (CTG) is excited to welcome Joe Deegan as a Managing Director in Atlanta. With over 30 years of experience in HR transformation and M&A advisory, Joe brings unparalleled expertise in helping corporate clients achieve accretive value with their M&A transaction strategy and execution, focusing on operational diligence, post-merger integration, and deal synergy realization. Joe's industry experience spans consumer goods, healthcare, and manufacturing with a focus on enterprise and operational transformation as well as employee engagement, productivity, and performance. He has led numerous global transactions to help his clients achieve enterprise and stakeholder value throughout the M&A lifecycle. Learn more: https://okt.to/ZXNhEm #AlvarezandMarsal #CorporateTransactionsGroup #AMon J. Preston Parker, Lyna Sun, Paul Aversano, Jeff Wilson, Colin Harvey, Kevin M.

We’re thrilled to welcome back Jim DeVerna as a Senior Director in our Compensation & Benefits practice in Denver. Jim’s return highlights the power of relationships and the unique culture at A&M. In his Q&A, he shares why he chose to rejoin, career lessons on adaptability and advice for professionals considering a return. Learn more about Jim’s journey here: https://okt.to/CtvT83 #AMon #AlumniNetwork #WelcomeBack

We are pleased to welcome Lorelei Heisler as a Senior Director with A&M’s Corporate Performance Improvement team in Seattle. With more than 30 years of consulting and business development experience, Lorelei brings expertise in finance transformation, M&A integration and global account expansion. She has a proven track record of supporting the offices of the CFO and the CAO and driving initiatives in technical accounting, risk, compliance, and licensing. Lorelei’s leadership and ability to build global client relationships will enhance our efforts to deliver impactful solutions for clients. Welcome aboard, Lorelei! https://okt.to/mZrbLB #AMon #AMonPI #Leadership #FinanceTransformation #BusinessDevelopment